SummitTX Capital’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
SummitTX Capital's KYMR Position: Q3 2026 in Review
SummitTX Capital opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 41,163 shares worth $4.6M. The stake represents 0.12% of the portfolio and ranks #203 among its holdings.
301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- SummitTX Capital held 41,163 shares of Kymera Therapeutics worth $4.6M as of Q3 2026.
- Kymera Therapeutics was a new SummitTX Capital position in Q3 2026.
- Kymera Therapeutics made up 0.12% of SummitTX Capital's portfolio in Q3 2026, its #203 holding.
- 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on SummitTX Capital's 13F filing for Q3 2026, filed 16 Nov 2026.